Molecular Mechanism of Avibactam-Mediated β-Lactamase Inhibition

ACS Infectious Diseases

Volumn 1, Issue 4, 2016, Pages 175-184

  King, Dustin T ^a   King, Andrew M ^b   Lal, Sarah M ^b   Wright, Gerard D ^b   Strynadka, Natalie C J ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

avibactam; inhibition; Lactamase

Indexed keywords

AVIBACTAM; BASE; BETA LACTAMASE;

ARTICLE; CARBAMOYLATION; COVALENT BOND; CRYSTAL STRUCTURE; DRUG BINDING; DRUG MECHANISM; ENZYME ASSAY; ENZYME INHIBITION; KINETICS; MUTANT; NONHUMAN; PRIORITY JOURNAL; SITE DIRECTED MUTAGENESIS;

EID: 84966302173     PISSN: None     EISSN: 23738227     Source Type: Journal    
DOI: 10.1021/acsinfecdis.5b00007     Document Type: Article

References (45)

1. Bush, K. (2010) Alarming β-lactamase-mediated resistance in multidrug-resistant Enterobacteriaceae Curr. Opin. Microbiol. 13, 558-564 10.1016/j.mib.2010.09.006
2. Bush, K. (2013) The ABCD's of β-lactamase nomenclature J. Infect. Chemother. 19, 549-559 10.1007/s10156-013-0640-7
3. Delmas, J., Chen, Y., Prati, F., Robin, F., Shoichet, B. K., and Bonnet, R. (2008) Structure and dynamics of CTX-M enzymes reveal insights into substrate accommodation by extended-spectrum beta-lactamases J. Mol. Biol. 375, 192-201 10.1016/j.jmb.2007.10.026
4. Golemi, D., Maveyraud, L., Vakulenko, S., Samama, J. P., and Mobashery, S. (2001) Critical involvement of a carbamylated lysine in catalytic function of class D beta-lactamases Proc. Natl. Acad. Sci. U.S.A. 98, 14280-14285 10.1073/pnas.241442898
5. Schneider, K. D., Karpen, M. E., Bonomo, R. A., Leonard, D. A., and Powers, R. A. (2009) The 1.4 A crystal structure of the class D beta-lactamase OXA-1 complexed with doripenem Biochemistry 48, 11840-11847 10.1021/bi901690r
6. Drawz, S. M. and Bonomo, R. A. (2010) Three decades of beta-lactamase inhibitors Clin Microbiol Rev. 23, 160-201 10.1128/CMR.00037-09
7. Helfand, M. S., Totir, M. A., Carey, M. P., Hujer, A. M., Bonomo, R. A., and Carey, P. R. (2003) Following the reactions of mechanism-based inhibitors with beta-lactamase by Raman crystallography Biochemistry 42, 13386-13392 10.1021/bi035716w
8. Bebrone, C., Lassaux, P., Vercheval, L., Sohier, J. S., Jehaes, A., Sauvage, E., and Galleni, M. (2010) Current challenges in antimicrobial chemotherapy: focus on β-lactamase inhibition Drugs 70, 651-679 10.2165/11318430-000000000-00000
9. Cantón, R., Morosini, M. I., Martín, O., de la Maza, O. M., and de la Pedrosa, E. G. (2008) IRT and CMT beta-lactamases and inhibitor resistance Clin Microbiol Infect 14, 53-62 10.1111/j.1469-0691.2007.01849.x
10. Lagacé-Wiens, P., Walkty, A., and Karlowsky, J. A. (2014) Ceftazidime-avibactam: an evidence-based review of its pharmacology and potential use in the treatment of Gram-negative bacterial infections Core Evid. 9, 13-25 10.2147/CE.S40698
11. Coleman, K. (2011) Diazabicyclooctanes (DBOs): a potent new class of non-β-lactam β-lactamase inhibitors Curr. Opin. Microbiol. 14, 550-555 10.1016/j.mib.2011.07.026
12. Ehmann, D. E., Jahic, H., Ross, P. L., Gu, R. F., Hu, J., Durand-Réville, T. F., Lahiri, S., Thresher, J., Livchak, S., Gao, N., Palmer, T., Walkup, G. K., and Fisher, S. L. (2013) Kinetics of avibactam inhibition against Class A, C, and D β-lactamases J. Biol. Chem. 288, 27960-27971 10.1074/jbc.M113.485979
13. Ehmann, D. E., Jahić, H., Ross, P. L., Gu, R. F., Hu, J., Kern, G., Walkup, G. K., and Fisher, S. L. (2012) Avibactam is a covalent, reversible, non-β-lactam β-lactamase inhibitor Proc. Natl. Acad. Sci. U.S.A. 109, 11663-11668 10.1073/pnas.1205073109
14. Lahiri, S. D., Mangani, S., Durand-Reville, T., Benvenuti, M., De Luca, F., Sanyal, G., and Docquier, J. D. (2013) Structural insight into potent broad-spectrum inhibition with reversible recyclization mechanism: avibactam in complex with CTX-M-15 and Pseudomonas aeruginosa AmpC β-lactamases Antimicrob. Agents Chemother. 57, 2496-2505 10.1128/AAC.02247-12
15. Xu, H., Hazra, S., and Blanchard, J. S. (2012) NXL104 irreversibly inhibits the β-lactamase from Mycobacterium tuberculosis Biochemistry 51, 4551-4557 10.1021/bi300508r
16. Lahiri, S. D., Mangani, S., Jahić, H., Benvenuti, M., Durand-Reville, T. F., De Luca, F., Ehmann, D. E., Rossolini, G. M., Alm, R. A., and Docquier, J. D. (2014) Molecular Basis of Selective Inhibition and Slow Reversibility of Avibactam against Class D Carbapenemases: A Structure-Guided Study of OXA-24 and OXA-48 ACS Chem. Biol. 10.1021/cb500703p
17. Poirel, L., Nordmann, P., Ducroz, S., Boulouis, H. J., Arné, P., and Millemann, Y. (2013) Extended-spectrum β-lactamase CTX-M-15-producing Klebsiella pneumoniae of sequence type ST274 in companion animals Antimicrob. Agents Chemother. 57, 2372-2375 10.1128/AAC.02622-12
18. Antunes, N. T., Lamoureaux, T. L., Toth, M., Stewart, N. K., Frase, H., and Vakulenko, S. B. (2014) Class D β-lactamases: are they all carbapenemases? Antimicrob. Agents Chemother. 58, 2119-2125 10.1128/AAC.02522-13
19. Zhang, L., Lü, X., and Zong, Z. (2013) The emergence of blaCTX-M-15-carrying Escherichia coli of ST131 and new sequence types in Western China Ann. Clin. Microbiol. Antimicrob. 12, 35 10.1186/1476-0711-12-35
20. Alexander, J. P. and Cravatt, B. F. (2005) Mechanism of carbamate inactivation of FAAH: implications for the design of covalent inhibitors and in vivo functional probes for enzymes Chem. Biol. 12, 1179-1187 10.1016/j.chembiol.2005.08.011
21. Mileni, M., Kamtekar, S., Wood, D. C., Benson, T. E., Cravatt, B. F., and Stevens, R. C. (2010) Crystal structure of fatty acid amide hydrolase bound to the carbamate inhibitor URB597: discovery of a deacylating water molecule and insight into enzyme inactivation J. Mol. Biol. 400, 743-754 10.1016/j.jmb.2010.05.034
22. Pattabiraman, V. R. and Bode, J. W. (2011) Rethinking amide bond synthesis Nature 480, 471-479 10.1038/nature10702
23. Yang, Q., Li, Y., Dou, D., Gan, X., Mohan, S., Groutas, C. S., Stevenson, L. E., Lai, Z., Alliston, K. R., Zhong, J., Williams, T. D., and Groutas, W. C. (2008) Inhibition of serine proteases by a new class of cyclosulfamide-based carbamylating agents Arch. Biochem. Biophys. 475, 115-120 10.1016/j.abb.2008.04.020
24. Lamotte-Brasseur, J., Dive, G., Dideberg, O., Charlier, P., Frère, J. M., and Ghuysen, J. M. (1991) Mechanism of acyl transfer by the class A serine beta-lactamase of Streptomyces albus G Biochem. J. 279, 213-221
25. Shimamura, T., Ibuka, A., Fushinobu, S., Wakagi, T., Ishiguro, M., Ishii, Y., and Matsuzawa, H. (2002) Acyl-intermediate structures of the extended-spectrum class A beta-lactamase, Toho-1, in complex with cefotaxime, cephalothin, and benzylpenicillin J. Biol. Chem. 277, 46601-46608 10.1074/jbc.M207884200
26. Pérez-Llarena, F. J., Kerff, F., Abián, O., Mallo, S., Fernández, M. C., Galleni, M., Sancho, J., and Bou, G. (2011) Distant and new mutations in CTX-M-1 beta-lactamase affect cefotaxime hydrolysis Antimicrob. Agents Chemother. 55, 4361-4368 10.1128/AAC.00298-11
27. Yasuyuki, F., Noriaki, O., Masayuki, H., Tetsu, N., Kenji, Y., Ryutaro, S., Atsushi, S., Noriyuki, F., Takahiro, K., Hideaki, F., Atsushi, K., Toshikazu, E., Saburo, N., and Tyuji, H. (2003) Molecular Dynamics Study on Class A β-Lactamase: Hydrogen Bond Network among the Functional Groups of Penicillin G and Side Chains of the Conserved Residues in the Active Site J. Phys. Chem. B 10274-10283 10.1021/jp034536t
28. Eisenmesser, E. Z., Millet, O., Labeikovsky, W., Korzhnev, D. M., Wolf-Watz, M., Bosco, D. A., Skalicky, J. J., Kay, L. E., and Kern, D. (2005) Intrinsic dynamics of an enzyme underlies catalysis Nature 438, 117-121 10.1038/nature04105
29. Lim, D. and Strynadka, N. C. (2002) Structural basis for the beta lactam resistance of PBP2a from methicillin-resistant Staphylococcus aureus Nat. Struct. Biol. 9, 870-876 10.1038/nsb858
30. De Luca, F., Benvenuti, M., Carboni, F., Pozzi, C., Rossolini, G. M., Mangani, S., and Docquier, J. D. (2011) Evolution to carbapenem-hydrolyzing activity in noncarbapenemase class D β-lactamase OXA-10 by rational protein design Proc. Natl. Acad. Sci. U.S.A. 108, 18424-18429 10.1073/pnas.1110530108
31. Chen, Y., Shoichet, B., and Bonnet, R. (2005) Structure, function, and inhibition along the reaction coordinate of CTX-M beta-lactamases J. Am. Chem. Soc. 127, 5423-5434 10.1021/ja042850a
32. Majiduddin, F. K., Materon, I. C., and Palzkill, T. G. (2002) Molecular analysis of beta-lactamase structure and function Int. J. Med. Microbiol. 292, 127-137 10.1078/1438-4221-00198
33. Lee, M., Hesek, D., and Mobashery, S. (2005) A Practical Synthesis of Nitrocefin J. Org. Chem. 70, 367-369 10.1021/jo0487395
34. Ehmann, D. E., Jahic, H., Ross, P. L., Gu, R. F., Hu, J., Durand-Reville, T. F., Lahiri, S., Thresher, J., Livchak, S., Gao, N., Palmer, T., Walkup, G. K., and Fisher, S. L. (2013) Kinetics of avibactam inhibition against Class A, C, and D beta-lactamases J. Biol. Chem. 288, 27960-27971 10.1074/jbc.M113.485979
35. Morrison, J. F. and Walsh, C. T. (1988) The behaviour and significance of slow-binding enzyme inhibitors Adv. Enzymol. Relat. Areas Mol. Biol. 61, 201 10.1002/9780470123072
36. Copeland, R. A., Basavapathruni, A., Moyer, M., and Scott, M. P. (2011) Impact of enzyme concentration and residence time on apparent activity recovery in jump dilution analysis Anal. Biochem. 416, 206-210 10.1016/j.ab.2011.05.029
37. Paetzel, M., Danel, F., de Castro, L., Mosimann, S. C., Page, M. G., and Strynadka, N. C. (2000) Crystal structure of the class D beta-lactamase OXA-10 Nat. Struct. Biol. 7, 918-925 10.1038/79688
38. Battye, T. G., Kontogiannis, L., Johnson, O., Powell, H. R., and Leslie, A. G. (2011) iMOSFLM: a new graphical interface for diffraction-image processing with MOSFLM Acta Crystallogr., D 67, 271-281 10.1107/S0907444910048675
39. Winn, M. D., Ballard, C. C., Cowtan, K. D., Dodson, E. J., Emsley, P., Evans, P. R., Keegan, R. M., Krissinel, E. B., Leslie, A. G., McCoy, A., McNicholas, S. J., Murshudov, G. N., Pannu, N. S., Potterton, E. A., Powell, H. R., Read, R. J., Vagin, A., and Wilson, K. S. (2011) Overview of the CCP4 suite and current developments Acta Crystallogr., D 67, 235-242 10.1107/S0907444910045749
40. McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C., and Read, R. J. (2007) Phaser crystallographic software J. Appl. Crystallogr. 40, 658-674 10.1107/S0021889807021206
41. Chen, Y., Delmas, J., Sirot, J., Shoichet, B., and Bonnet, R. (2005) Atomic resolution structures of CTX-M beta-lactamases: extended spectrum activities from increased mobility and decreased stability J. Mol. Biol. 348, 349-362 10.1016/j.jmb.2005.02.010
42. Docquier, J. D., Calderone, V., De Luca, F., Benvenuti, M., Giuliani, F., Bellucci, L., Tafi, A., Nordmann, P., Botta, M., Rossolini, G. M., and Mangani, S. (2009) Crystal structure of the OXA-48 beta-lactamase reveals mechanistic diversity among class D carbapenemases Chem. Biol. 16, 540-547 10.1016/j.chembiol.2009.04.010
43. Emsley, P., Lohkamp, B., Scott, W. G., and Cowtan, K. (2010) Features and development of Coot Acta Crystallogr., D 66, 486-501 10.1107/S0907444910007493
44. Schrödinger, L. The PyMOL Molecular Graphics System, Version 1.5.0.4.
45. Laskowski, R. A. and Swindells, M. B. (2011) LigPlot+: multiple ligand-protein interaction diagrams for drug discovery J. Chem. Inf Model. 51, 2778-2786 10.1021/ci200227u